«Отсроченное Материнство»: Современные возможности сохранения репродуктивного потенциала

1. Liu K., Case A. Advanced reproductive age and fertility. J. Obstet. Gynaecol. Can. 2011; 33(11): 1165-75.
2. Сыркашева А.Г., Ильина Е.О., Долгушина Н.В. Бесплодие у женщин старшего репродуктивного возраста: причины, тактика ведения, перспективы использования преимплантационного генетического скрининга (обзор литературы). Гинекология. 2016; 18(3): 40-3.
3. Долгушина Н.В., Коротченко О.Е., Бейк Е.П., Абдурахманова Н.Ф., Ильина Е.О., Кулакова Е.В. Клинико-экономический анализ эффективности преимплантационного генетического скрининга у пациенток позднего репродуктивного возраста. Акушерство и гинекология. 2017; 11: 56-61.
4. Bukulmez O., Arici A. Assessment of ovarian reserve. Curr. Opin. Obstet. Gynecol. 2004; 16(3): 231-7.
5. Kuliev A., Cieslak J., Verlinsky Y. Frequency and distribution of chromosome abnormalities in human oocytes. Cytogenet. Genome Res. 2005; 111(3-4): 193-8.
6. Баранов В.С., Кузнецова Т.В. Цитогенетика эмбрионального развития человека. СПб.; 2007. 75c.
7. Pellestor F., Andréo B., Arnal F., Humeau C., Demaille J. Maternal aging and chromosomal abnormalities: new data drawn from in vitro unfertilized human oocytes. Hum. Genet. 2003; 112(2): 195-203.
8. Johnson J., Tough S.; SOGC GENETICS COMMITTEE. Delayed child-bearing. J. Obstet. Gynaecol. Can. 2012; 34(1): 80-93.
9. Martinez F. Update on fertility preservation from the Barcelona International Society for Fertility Preservation – ESHRE – ASRM 2015 expert meeting : indications. Hum. Reprod. 2017; 32(9): 1802-11.
10. Ethics Committee of American Society for Reproductive Medicine. Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion. Fertil. Steril. 2013; 100(5): 1224-31.
11. Joshi S., Savani B., Chow E., Gilleece M., Halter J., Jacobsohn D. et al. Clinical guide to fertility preservation in hematopoietic cell transplant recipients. Bone Marrow Transplant. 2015; 49(4): 477-84.
12. ESHRE POI Guideline Development Group. Guideline on the management of premature ovarian insufficiency. European Society of Human Reproduction and Embryology; 2015.
13. Borini A., Bianchi V. Cryopreservation of mature and immature oocytes. Clin. Obstet. Gynecol. 2010; 53(4): 763-74.
14. Saragusty J., Arav A. Current progress in oocyte and embryo cryopreservation by slow freezing and vitrification. Reproduction. 2011; 141(1): 1-19.
15. Kuwayama M., Vajta G., Ieda S., Kato O. Comparison of open and closed methods for vitrification of human embryos and the elimination of potential contamination. Reprod. Biomed. Online. 2005; 11(5): 608-14.
16. Antinori M., Licata E., Dani G., Cerusico F., Versaci C., Antinori S. Cryotop vitrification of human oocytes results in high survival rate and healthy deliveries. Reprod. Biomed. Online. 2007; 14(1): 72-9.
17. De Munck N., Vajta G. Safety and efficiency of oocyte vitrification. Cryobiology. 2017; 78: 119-27. Available at: http://dx.doi.org/10.1016/j.cryobiol.2017.07.009
18. Cobo A., Serra V., Garrido N., Olmo I., Pellicer A., Remohi J. Obstetric and perinatal outcome of babies born from vitrified oocytes. Fertil. Steril. 2014; 102(4): 1006-15. e4.
19. Smith G.D., Serafini P.C., Fioravanti J., Yadid I., Coslovsky M., Hassun P. et al. Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrification. Fertil. Steril. 2010; 94(6): 2088-95.
20. Cobo A., García-Velasco J.A. Why all women should freeze their eggs. Curr. Opin. Obstet. Gynecol. 2016; 28(3): 206-10.
21. Cobo A., Garrido N., Pellicer A., Remohi J. Six years’ experience in ovum donation using vitrified oocytes: report of cumulative outcomes, impact of storage time, and development of a predictive model for oocyte survival rate. Fertil. Steril. 2015; 104(6): 1426-34. e1-8.
22. Devine K., Stillman R.J., De Cherney A.H. Building a family through in vitro fertilization--economic realities. Fertil. Steril. 2015; 103(2): 357-8.
23. Doyle J.O., Richter K.S., Lim J., Stillman R.J., Graham J.R., Tucker M.J. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval. Fertil. Steril. 2016; 105(2): 459-66. e2.

Поступила 06.04.2018

Принята в печать 20.04.2018